Le Lézard
Classified in: Health
Subjects: NPT, SVY, POL, AVO

New Report on Prescription Drug Costs: PBMs "Rife with Potential Conflicts of Interest"


WASHINGTON, Dec. 12, 2017 /PRNewswire-USNewswire/ -- In thanking U.S. Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Lamar Alexander (R-TN) and Ranking Member Patty Murray (D-WA) for holding its third 2017 hearing on rising prescription drug costs and associated issues, the Senior Care Pharmacy Coalition (SCPC) pointed out a new study -- the subject of today's hearing ? which specifically notes the pharmacy benefit manager (PBM) business model is "rife with potential conflicts of interest."

"Every American who needs and deserves affordable prescription medications will benefit from the HELP Committee's ongoing examination of rising drug costs, and we are pleased the new report by the National Academies of Sciences, Engineering and Medicine helps detail how PBMs are central to perpetuating a lack of transparency negatively impacting consumers," said Alan G. Rosenbloom, President and CEO of SCPC -- the only federal advocacy organization devoted exclusively to the interests of the nation's LTC pharmacies and the patients they serve.

The new study, "Making Medicines Affordable: A National Imperative," from the National Academies of Sciences, Engineering and Medicine, states the following:  

"...The United States biopharmaceutical enterprise has evolved into a supremely complex amalgam of regulators, developers and manufacturers, retailers, insurers, wholesalers, physicians, employers offering benefits, and intermediaries including organizations referred to as pharmacy benefit managers. The role of the latter is to support the overall pharmaceutical enterprise, providing such services as negotiating prices, establishing formularies (lists of drugs to be covered by insurance) and handling administrative functions...

"In addition, some pharmacy benefit managers operate their own mail-order and retail pharmacies. Not surprisingly, the system is rife with potential conflicts of interest." (Preface, Page 10)

Stated Rosenbloom: "The nation's three major PBMs ? CVS Caremark, Express Scripts and Optum Rx ? control more than 80 percent of prescriptions dispensed in America. For patients living in the nation's long term care (LTC) facilities, this percentage jumps to more than 90 percent. This degree of market control by so few companies, which also are part of health care conglomerates rife with conflicts of interest, facilitates PBMs' ability to manipulate prices, gouge consumers and side-step accountability. The bottom line is that the PBM oligopoly maintains an anti-competitive stranglehold on LTC pharmacies and patients under their care."

Rosenbloom said this anti-competitive environment, which has evolved rapidly since the inception of Medicare Part D and accelerated dramatically in just the past few years, "demands much closer public scrutiny and government oversight than in years past." He also noted the recently announced pharmacy giant CVS Health acquisition of America's third-largest health insurer, Aetna, "represents another dangerous step toward governmental acceptance of an increasingly integrated, consolidated and oligopolistic system effectively allowing a shrinking number of mega-companies to control every aspect of health care."

The SCPC is the national association for independent LTC pharmacies. Our member pharmacies provide care and services to patients in LTC facilities across the country occupying approximately 675,000 beds. Visit seniorcarepharmacies.org to learn more.

 

SOURCE Senior Care Pharmacy Coalition


These press releases may also interest you

at 06:08
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...

at 05:45
The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to  ResearchAndMarkets.com's offering....

at 05:45
The Gross Law Firm issues the following notice to shareholders of InMode Ltd. . Shareholders who purchased shares of INMD during the...

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...



News published on and distributed by: